IFNG and COVID-19: In the COVID-19 with allergy group, 1 in 8 patients had an IFN-γ beyond the detection range, and 5 of the remaining 7 patients had IFN-γ values which increased in the spike stimulation group when compared with the PBS control group (p=0.055).